CDNA

CareDx, Inc
$28.51
-0.60 (-2.06%)
Mkt Cap 1.47B
Volume 639,156
52W Range 10.96-30
Sector Healthcare
Beta 2.43
EPS (TTM) -0.16
P/E Ratio -47.10
Revenue (TTM) 412.82M
Rev Growth (5Y) +14.6%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
What we estimate one share is worth
$12.01
Overvalued strong signal
137.4% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Platform & Compounding FCF
30.0 / 100 pillar composite (overridden)
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 379.81M 333.79M 280.32M 321.79M 296.40M 192.19M 127.07M 76.57M 48.32M 40.63M 28.14M 27.31M
Net Income (21.35M) 52.55M (190.28M) (76.61M) (30.66M) (18.71M) (21.97M) (46.76M) (55.47M) (39.47M) (13.71M) 781,000
EPS -0.40 1.00 -3.54 -1.44 -0.59 -0.40 -0.52 -1.31 -2.38 -2.39 -1.16 0.13
Free Cash Flow 36.12M 31.56M (27.63M) (49.57M) (39.55M) 23.07M (6.12M) (11.24M) (14.49M) (17.07M) (10.95M) (4.08M)
FCF / Share 0.68 0.60 -0.51 -0.93 -0.76 0.50 -0.15 -0.32 -0.62 -1.03 -0.93 -0.70
Operating CF 42.03M 38.05M (18.39M) (25.24M) (19.29M) 33.43M (2.77M) (4.01M) (14.31M) (16.52M) (9.75M) (3.35M)
Total Assets 413.23M 491.05M 466.83M 542.99M 566.62M 368.51M 151.74M 130.70M 83.56M 76.73M 55.64M 61.14M
Total Debt 26.19M 28.37M 34.22M 39.00M 21.35M 18.10M 5.39M 172,000 34.06M 23.94M 15.75M 11.41M
Cash & Equiv 65.43M 114.69M 82.20M 89.92M 348.49M 134.67M 38.22M 64.62M 16.89M 17.26M 29.89M 36.43M
Book Value 303.10M 378.43M 261.33M 430.91M 465.88M 277.68M 99.00M 95.93M (6.13M) 19.48M 29.49M 41.30M
Return on Equity -0.07 0.14 -0.73 -0.18 -0.07 -0.07 -0.22 -0.49 N/A -2.03 -0.46 0.02
CDNA News
CareDx Completes Naveris Acquisition and Expands Oncology Reach
Jul 07, 2026 08:26 AM · zacks.com
CareDx: The Transplant Platform Is Becoming A Specialty Diagnostics Compounder
Jul 07, 2026 04:01 AM · seekingalpha.com
CareDx Completes Acquisition of Naveris, Extending Leadership into High-Growth Specialty Oncology
Jul 01, 2026 12:05 PM · businesswire.com
CareDx Announces Completion of Sale of Lab Products Business to Eurobio Scientific
Jun 30, 2026 12:05 PM · businesswire.com
CareDx's CEO Sells 17K Shares
Jun 21, 2026 05:38 PM · fool.com
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last?
Jun 19, 2026 04:41 AM · zacks.com
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress
Jun 18, 2026 03:05 AM · businesswire.com
CareDx Inc (CDNA) Shares Fall 3.4% -- GF Value Says Still Overvalued
Jun 16, 2026 04:03 PM · gurufocus.com
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
Jun 16, 2026 12:05 PM · businesswire.com
CareDx Sharpens Precision Diagnostics Push With Naveris Deal, AlloHeme Plans
Jun 08, 2026 04:04 PM · marketbeat.com